ArticleFrontiers in immunology2025

Comparison of efficacy and adverse effects of CD19/20 CART versus CD19 single-target CART in R/R DLBCL: a single-center retrospective study.

Bin Xue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.